LGND Ligand Pharmaceuticals Incorporated
293.26USD-1.24%Mkt Cap: 5.85B $P/E: 30.901d ago
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for …
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap5.85B USD
Enterprise Value5.70B USD
Revenue (TTM)290.54M USD
Gross Profit253.54M USD
Net Income (TTM)124.45M USD
Revenue/Share14.75 USD
Last Price293.26 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)30.90
P/E (Forward)24.85
PEG1.53
EV/EBITDA42.83
EV/Revenue19.61
P/S20.37
P/B6.11
EPS (TTM)9.49
EPS (Forward)11.95
52W Range
163.4581% of range323.33
52W High323.33 USD
52W Low163.45 USD
Profitability
Gross Margin94.57%
Oper. Margin13.49%
EBITDA Margin45.78%
Profit Margin46.42%
ROE12.23%
ROA7.97%
Growth
Revenue Growth33.70%
Earnings Growth825.00%
Cash Flow & Leverage
Operating CF49.36M USD
CapEx (TTM)11.31M USD
FCF Margin48.10%
FCF Yield2.39%
Net Debt-226.30M USD
Net Debt/EBITDA-1.70
Balance Sheet
Debt/Equity0.44
Current Ratio31.18
Quick Ratio30.83
Book Value/Sh48.57 USD
Cash/Share68.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 2, 2010
Pay Date—
Splits
Last Split1603:1000
Split DateNov 2, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)344.25 USD
Upside (mean)+17.4%
Target Range247.00 USD – 397.00 USD
247.00+17.4% to mean397.00
# Analysts12
Ownership
Shares Out.19.94M
Float19.48M
Insiders2.34%
Institutions116.13%
Short Interest
Short Ratio14.1d
Short % Float15.83%
Short % Out.13.20%
Shares Short2.63M
Short (prev mo.)2.45M
Technical
SMA 50291.85 (+0.5%)
SMA 200242.84 (+20.8%)
Beta1.01
S&P 52W Chg16.45%
Avg Vol (30d)234.27K
Avg Vol (10d)281.44K
Technical Indicators
RSI (14)47.4
MACD3.1601
MACD Signal3.4021
MACD Hist.-0.2420
BB Upper317.49 USD
BB Middle295.85 USD
BB Lower274.21 USD
BB Width14.63%
ATR (14)9.972 USD
Vol Ratio (20d)1.19x